Abstract
Hepatitis C virus (HCV) causes a persistent infection, chronic hepatitis and hepatocellular carcinoma. HCV NS5A, one of non-structural proteins of HCV, was suggested to play a role in oncogenic transformation. Since the tumor suppressor p53 is important for preventing neoplastic transformation, we investigated the functional effects of HCV NS5A on p53. In vitro and in vivo coimmunoprecipitation and confocal microscopy were used to determine the interaction of NS5A and p53. HCV NS5A binds directly to p53 and colocalizes p53 in the perinuclear region. NS5A inhibits transcriptional transactivation by p53 in a dose-dependent manner by use of a reporter assay. Down regulation of endogenous p21/waf1 expression, which is activated by p53 in Hep3B cells, by NS5A was demonstrated by using FLAG- and FLAG-NS5A Hep3B stable cell lines. The effect of NS5A on p53-mediated apoptosis was determined by flow cytometry in both NS5A permanently and transiently transfected Hep3B cells with exogenous p53. The p53-induced apoptosis was abrogated by NS5A and the inhibition effect correlates well with the binding ability of NS5A to p53. In addition, HCV NS5A protein interacts with and colocalizes hTAFII32, a component of TFIID and an essential coactivator of p53, in vivo. These results suggest that HCV NS5A interacts with and partially sequestrates p53 and hTAFII32 in the cytoplasm and suppresses p53-mediated transcriptional transactivation and apoptosis during HCV infection, which may contribute to the hepatocarcinogenesis of HCV infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen X, Ko LJ, Jayaraman L, Prives C . 1996 Genes Dev. 10: 2438–2451
Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley D, Kuo G, Houghton M . 1991 Proc. Natl. Acad. Sci. USA 88: 2451–2455
Chung KM, Song OK, Jang SK . 1997 Mol. Cell. 7: 661–667
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH . 1993 Nature 362: 849–852
Dobner T, Horikoshi N, Rubenwolf S, Shenk T . 1996 Science 272: 1470–1473
Dyson N, Howley PM, Munger K, Harlow E . 1989 Science 243: 934–937
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M . 1989 Proc. Natl. Acad. Sci. USA 86: 8763–8767
Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC . 1997 Proc. Natl. Acad. Sci. USA 94: 14707–14712
Finlay CA, Hinds PW, Levine AJ . 1989 Cell 57: 1083–1093
Fukuma T, Enomoto N, Marumo F, Sato C . 1998 Hepatology 28: 1147–1153
Gale Jr M, Kwieciszewski B, Dossett M, Nakao H, Katze MG . 1999 J. Virol. 73: 6506–6516
Ghosh AK, Steele R, Meyer K, Ray R, Ray RB . 1999 J. Gen. Virol. 80: 1179–1183
Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM . 1993 J. Virol. 67: 1385–1395
Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K . 1991 Proc. Natl. Acad. Sci. USA 88: 5547–5551
Houghton M . 1996 Fields Virology Fields BN, DMK, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B and Straus SE (eds) Philadelphia: Lippincott-Raven Publishers pp 1035–1058
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC . 1991 Nature 350: 427–428
Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R . 1996 Gene 182: 203–211
Ingles CJ, Shales M, Cress WD, Triezenberg SJ, Greenblatt J . 1991 Nature 351: 588–590
Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K . 1994 Biochem. Biophys. Res. Commun. 205: 320–326
Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K . 1990 Proc. Natl. Acad. Sci. USA 87: 9524–9528
Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M . 1997 J. Virol. 71: 8856–8859
Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M . 1989 Science 244: 362–364
Lane DP . 1992 Nature 358: 15–16
Lane DP, Crawford LV . 1979 Nature 278: 261–263
Levine AJ . 1993 Annu. Rev. Biochem. 62: 623–651
Levine AJ . 1997 Cell 88: 323–331
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R . 1999 Science 285: 110–113
Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T . 1994 Science 266: 807–810
Lowe SW, Ruley HE, Jacks T, Housman DE . 1993a Cell 74: 957–967
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T . 1993b Nature 362: 847–849
Lu H, Levine AJ . 1995 Proc. Natl. Acad. Sci. USA 92: 5154–5158
Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH . 1999 Virology 264: 134–141
Majumder M, Ghosh AK, Steele R, Ray R, Ray RB . 2001 J. Virol. 75: 1401–1407
Moradpour D, Kary P, Rice CM, Blum HE . 1998 Hepatology 28: 192–201
Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam C, Franchini G . 1998 J. Virol. 72: 8852–8860
Muralidhar S, Doniger J, Mendelson E, Araujo JC, Kashanchi F, Azumi N, Brady JN, Rosenthal LJ . 1996 J. Virol. 70: 8691–8700
Neil JC, Cameron ER, Baxter EW . 1997 Trends Microbiol. 5: 115–120
Niwa H, Yamamura K, Miyazaki J . 1991 Gene 108: 193–199
Ohashi M, Kanai F, Ueno H, Tanaka T, Tateishi K, Kawakami T, Koike Y, Ikenoue T, Shiratori Y, Hamada H, Omata M . 1999 Gut 44: 366–371
Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M . 2000 J. Biol. Chem. 275: 34122–34130
Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN . 1998 J. Virol. 72: 1165–1170
Polyak SJ, Paschal DM, McArdle S, Gale Jr MJ, Moradpour D, Gretch DR . 1999 Hepatology 29: 1262–1271
Prost S, Ford JM, Taylor C, Doig J, Harrison DJ . 1998 J. Biol. Chem. 273: 33327–33332
Ray RB, Steele R, Meyer K, Ray R . 1997 J. Biol. Chem. 272: 10983–10986
Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q, Houghton M, Kuo G . 1990 Proc. Natl. Acad. Sci. USA 87: 6547–6549
Sarnow P, Ho YS, Williams J, Levine AJ . 1982 Cell 28: 387–394
Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K . 2000 Virology 270: 476–487
Scheffner M, Takahashi T, Huibregtse JM, Minna JD, Howley PM . 1992 J. Virol. 66: 5100–5105
Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V . 1991 Oncogene 6: 2055–2065
Sheppard HM, Corneillie SI, Espiritu C, Gatti A, Liu X . 1999 Mol. Cell. Biol. 19: 2746–2753
Shieh YS, Nguyen C, Vocal MV, Chu HW . 1993 Int. J. Cancer 54: 558–562
Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, Ogura K, Niwa Y, Kawabe T, Omata M . 1995 Hepatology 22: 1027–1033
Stringer KF, Ingles CJ, Greenblatt J . 1990 Nature 345: 783–786
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T . 1994 Cell 78: 703–711
Takada S, Kaneniwa N, Tsuchida N, Koike K . 1997 Oncogene 15: 1895–1901
Tanimoto A, Ide Y, Arima N, Sasaguri Y, Padmanabhan R . 1997 Biochem. Biophys. Res. Commun. 236: 360–364
Thompson CB . 1995 Science 267: 1456–1462
Thut CJ, Chen JL, Klemm R, Tjian R . 1995 Science 267: 100–104
Uchida T, Takahashi K, Tatsuno K, Dhingra U, Eliason JF . 1996 Int. J. Cancer 67: 892–897
Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G . 1995 Nat. Genet. 9: 41–47
Uesugi M, Nyanguile O, Lu H, Levine AJ, Verdine GL . 1997 Science 277: 1310–1313
Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC . 1994 Proc. Natl. Acad. Sci. USA 91: 2230–2234
Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC . 1995 Cancer Res. 55: 6012–6016
Zantema A, Fransen JA, Davis-Olivier A, Ramaekers FC, Vooijs GP, DeLeys B, van der Eb A . 1985a Virology 142: 44–58
Zantema A, Schrier PI, Davis-Olivier A, van Laar T, Vaessen RT, van der Eb A . 1985b Mol. Cell. Biol. 5: 3084–3091
Acknowledgements
We thank Junichi Miyazaki, Yan-Hwa Wu Lee, Robert Tijin for their gifts of plasmids and Xin Wei Wang (NCI, NIH, USA) for reviewing this manuscript. The study was partially supported by grants from the National Science Council, Taiwan (NSC 89-2315-B-075-002 and NSC 90-2314-B-075-037-MH).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lan, KH., Sheu, ML., Hwang, SJ. et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801–4811 (2002). https://doi.org/10.1038/sj.onc.1205589
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205589
Keywords
This article is cited by
-
Major genomic mutations driving hepatocellular carcinoma
Genome Instability & Disease (2023)
-
Serine-arginine protein kinases and their targets in viral infection and their inhibition
Cellular and Molecular Life Sciences (2023)
-
A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection
Scientific Reports (2022)
-
Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies
Cellular and Molecular Life Sciences (2021)
-
Chronic Hepatitis C Virus Infection is Associated with an Increased Risk of Lung Cancer: A Systematic Review and Meta-analysis
Lung (2020)